This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Novavax shows 90 percent efficacy in large U S Mexico study
Novavax reports its COVID-19 vaccine is about 90 percent effective overall in a large U S and Mexico trial involving nearly 30 000 adults. The study found protection against variants with a favorable safety profile and potential for broad global use.
MENTIONED IN THIS ARTICLE
Novavax
U.S
Mexico
Pfizer
Moderna
Europe
Stanley Erck
Developing World
University of Oxford
Johnson & Johnson
Britain
Paul Heath
Vaccine Institute
University of London
St. George's Hospital
Erek
Kelechi Chikere
Gaithersburg
South Africa